Paraneoplastic scleroderma in the setting of CD30+ large cell transformation of mycosis fungoides

Dawn Queen; Adriana Lopez; Larisa J Geskin

doi:10.1016/j.jdcr.2018.11.014

Paraneoplastic scleroderma in the setting of CD30⁺ large cell transformation of mycosis fungoides

JAAD Case Rep. 2019 Jan 31;5(2):201-204. doi: 10.1016/j.jdcr.2018.11.014. eCollection 2019 Feb.

Authors

Dawn Queen¹, Adriana Lopez¹, Larisa J Geskin²

Affiliations

¹ Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
² Columbia University Medical Center, Department of Dermatology, New York, New York.

No abstract available

Keywords: BV, brentuximab vedotin; FGF, fibroblast growth factor; IL, interleukin; MF, mycosis fungoides; Scl-70, DNA topoisomerase I; TGF-β, transforming growth factor β; Th2, helper T cell 2; cutaneous T cell lymphoma; immunotherapy; mycosis fungoides; paraneoplastic; scleroderma.

Publication types

Case Reports